We selected immune cells with the most different infiltration under TNBC, Her2, ER, and PR groups, respectively, resulting in 16 immune cells with distinct infiltration among Her2, ER, and PR expression in breast cancer (Fig. 5C-F). The gene discussed is ESR1; the disease is breast carcinoma.